Literature DB >> 18555829

Interorgan synthesis of arginine is down-regulated in tumor-bearing mice undergoing surgical trauma.

Yvonne L J Vissers1, Maarten F von Meyenfeldt, Yvette C Luiking, Cornelis H C Dejong, Nicolaas E P Deutz.   

Abstract

Renal de novo arginine production has been suggested to be crucial for regulation of arginine production in disease. We investigated how the interorgan pathway for de novo arginine production is affected by the presence of malignant tumor and/or surgical trauma. Controls and methylcholanthrene-sarcoma-bearing mice were studied, both with and without undergoing laparotomy (n = 9-13 per group). One day after laparotomy, amino acid fluxes across the hindquarter, intestine, liver, and kidney were studied. In contrast to healthy mice, the liver of tumor-bearing mice took up citrulline (9 +/- 3 vs 1 +/- 2 nmol/[10 g min], P < .05), simultaneous with attenuated renal arginine output (4 +/- 3 vs 12 +/- 2 nmol/[10 g min], P < .05), despite increased intestinal conversion of glutamine to citrulline (15 +/- 3 vs 8 +/- 1 nmol/[10 g min], P < .05). In tumor-bearing mice undergoing surgery, intestinal citrulline output decreased (from 15 +/- 3 to 8 +/- 2 nmol/[10 g min], P < .05) and renal arginine output remained close to zero despite increased renal citrulline uptake (from 6 +/- 2 to 12 +/- 2 nmol/[10 g min], P < .05). In conclusion, the interorgan pathway for de novo arginine production was differently regulated depending on the pathophysiological situation. In methylcholanthrene-sarcoma-bearing mice, decreased de novo arginine production was accompanied by the presence of hepatic citrulline uptake, whereas tumor-bearing mice subjected to surgical trauma showed concomitant decreased intestinal citrulline output.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18555829     DOI: 10.1016/j.metabol.2008.02.003

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  4 in total

1.  Major surgery diminishes systemic arginine availability and suppresses nitric oxide response to feeding in patients with early stage breast cancer.

Authors:  Mariëlle P K J Engelen; V Suzanne Klimberg; Arianna Allasia; Nicolaas E P Deutz
Journal:  Clin Nutr       Date:  2017-08-05       Impact factor: 7.324

2.  Muscle protein synthesis in cancer patients can be stimulated with a specially formulated medical food.

Authors:  Nicolaas E P Deutz; Ahmed Safar; Scott Schutzler; Robert Memelink; Arny Ferrando; Horace Spencer; Ardy van Helvoort; Robert R Wolfe
Journal:  Clin Nutr       Date:  2011-06-16       Impact factor: 7.324

Review 3.  Arginine de novo and nitric oxide production in disease states.

Authors:  Yvette C Luiking; Gabriella A M Ten Have; Robert R Wolfe; Nicolaas E P Deutz
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-09-25       Impact factor: 4.310

Review 4.  Thyroid hormone action in epidermal development and homeostasis and its implications in the pathophysiology of the skin.

Authors:  G Mancino; C Miro; E Di Cicco; M Dentice
Journal:  J Endocrinol Invest       Date:  2021-03-08       Impact factor: 4.256

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.